GlaxoSmithKline and Access to Essential Medicines (B)

&
Journal of Business Ethics Education 2 (1):123-132 (2005)
  Copy   BIBTEX

Abstract

The (B) case summarizes GSK’s response to pressures to increase access to essential medicines in developing countries and subsequent developments.

Categories

Keywords

Reprint years

ISBN(s)

16495195

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,503

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

My notes

Similar books and articles

GlaxoSmithKline and Access to Essential Medicines (B).N. Craig Smith & Anne Duncan - 2005 - Journal of Business Ethics Education 2 (1):123-132.
Global health impact: A basis for labeling and licensing campaigns?Nicole Hassoun - 2012 - Developing World Bioethics 12 (3):121-134.
Patent Funded Access to Medicines.Tom Andreassen - 2014 - Developing World Bioethics 15 (3):152-161.
Pharmaceutical Companies and Global Lack of Access to Medicines: Strengthening Accountability under the Right to Health.Anand Grover, Brian Citro, Mihir Mankad & Fiona Lander - 2012 - Journal of Law, Medicine and Ethics 40 (2):234-250.
Access to Medicines in Developing Countries: Ethical Demands and Moral Economy.Marilena Correa Maurice Cassier - 2014 - Developing World Bioethics 14 (2):ii-viii.
Developing Nations and the Compulsory License: Maximizing Access to Essential Medicines While Minimizing Investment Side Effects.Robert C. Bird - 2009 - Journal of Law, Medicine and Ethics 37 (2):209-221.
Access to Medicines and Distributive Justice: Breaching Doha's Ethical Threshold.Rachel Kiddell-Monroe - 2014 - Developing World Bioethics 14 (2):59-66.
Human Rights Responsibilities of Pharmaceutical Companies in Relation to Access to Medicines.Joo-Young Lee & Paul Hunt - 2012 - Journal of Law, Medicine and Ethics 40 (2):220-233.
Narrowing the gap: access to HIV treatments in developing countries. A pharmaceutical company's perspective.J. Cochrane - 2000 - Journal of Medical Ethics 26 (1):47-50.
Improving access to essential medicines: How health concerns can be prioritised in the global governance system.Devi Sridhar - 2008 - Public Health Ethics 1 (2):83-88.
Rationing the access to high cost medicines in developing countries.Debora Diniz - 2009 - Developing World Bioethics 9 (2):ii-iii.
Access to Medicines in Developing Countries: Ethical Demands and Moral Economy.Maurice Cassier & Marilena Correa - 2014 - Developing World Bioethics 14 (2):ii-viii.
Patents and access to drugs in developing countries: An ethical analysis.Sigrid Sterckx - 2004 - Developing World Bioethics 4 (1):58–75.
Race against time: The export of essential medicines to rwanda.Matthew Rimmer - 2008 - Public Health Ethics 1 (2):89-103.
Corporate Responsibilities for Access to Medicines.Klaus M. Leisinger - 2009 - Journal of Business Ethics 85 (S1):3 - 23.

Analytics

Added to PP
2012-03-18

Downloads
75 (#218,978)

6 months
13 (#189,362)

Historical graph of downloads
How can I increase my downloads?

Citations of this work

No citations found.

Add more citations

References found in this work

No references found.

Add more references